(RTTNews) - Amneal Pharmaceuticals, Inc. (AMRX) announced that the U.S. FDA has approved its Epinephrine injection USP, 1 mg/mL, in both single-dose and multi-dose for use in U.S. hospitals.

FRANKFURT (Reuters) - The European Union's healthcare regulator will this week review the use of Eli Lilly's approved Mounjaro drug against diabetes and obesity when prefilled in a multi-dose ...

Zydus Lifesciences on Saturday announced the launch of Semaglutide Injection in India under the brand names SEMAGLYN™, MASHEMA™ and ALTERME™, following patent expiry.

This approval provides patients with a new generic option for the folate analog metabolic inhibitor, which is used to treat ...

The approval expands Amneal’s injectables portfolio with an essential medicine used in hospitals for emergency and perioperative care. Epinephrine is a non-selective alpha and beta adrenergic agonist.

Atropine is a muscarinic antagonist and is indicated for temporary blockage of severe or life threatening muscarinic effects. Atropine Sulfate Injection is now available in an 8mg per 20mL ...

> Genentech has introduced a new pre-filled, multi-dose injection device for the administration of Nutropin AQ, a recombinant growth hormone for patients with growth disorders. "NuSpin" is the first ...

Expands Amneal’s injectables portfolio with an essential medicine used in hospitals for emergency and perioperative care BRIDGEWATER, N.J., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, ...

Alembic Pharmaceuticals (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Methotrexate ...

Acetaminophen Injection may be given as a single or repeated dose for the treatment of acute pain or fever. The Food and Drug Administration (FDA) has approved Acetaminophen Injection in multiple ...